酪氨酸磷酸酶激活在阿尔茨海默病进展中的作用 - Suppr

Suppr

超能文献

Activation of tyrosine phosphatases in the progression of Alzheimer's disease.

作者信息

Stewart Alexandre F R, Chen Hsiao-Huei

机构信息

University of Ottawa Heart Institute, Ottawa, Canada.

Ottawa Hospital Research Institute, Ottawa, Canada.

出版信息

Neural Regen Res. 2020 Dec;15(12):2245-2246. doi: 10.4103/1673-5374.284986.

DOI:10.4103/1673-5374.284986

PMID:32594039

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7749463/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abe5/7749463/ee4e38f4a8e5/NRR-15-2245-g001.jpg

相似文献

Activation of tyrosine phosphatases in the progression of Alzheimer's disease.酪氨酸磷酸酶激活在阿尔茨海默病进展中的作用

Neural Regen Res. 2020 Dec;15(12):2245-2246. doi: 10.4103/1673-5374.284986.

Drastic reduction of the zinc- and magnesium-stimulated protein tyrosine kinase activities in Alzheimer's disease hippocampus.

FEBS Lett. 1993 Aug 9;328(1-2):6-8. doi: 10.1016/0014-5793(93)80953-r.

Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease.阿尔茨海默病中具有M期类型改变的成人大脑神经元中的组成型Cdc25B酪氨酸磷酸酶活性

Neuroscience. 2001;105(3):639-50. doi: 10.1016/s0306-4522(01)00219-6.

Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.对集落刺激因子1受体（CSF1R）进行药物靶向治疗可抑制小胶质细胞增殖，并预防阿尔茨海默病样病理进程。

Brain. 2016 Mar;139(Pt 3):891-907. doi: 10.1093/brain/awv379. Epub 2016 Jan 8.

Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease.小胶质细胞激活的不同动态特征与阿尔茨海默病的进展相关。

Brain. 2018 Jun 1;141(6):1855-1870. doi: 10.1093/brain/awy079.

Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.阿尔茨海默病中的神经原纤维变性：从分子机制到药物靶点的鉴定

Curr Opin Psychiatry. 2008 Nov;21(6):555-61. doi: 10.1097/YCO.0b013e328314b78b.

Hypothalamic digoxin, hemispheric chemical dominance, and Alzheimer's disease.下丘脑地高辛、半球化学优势与阿尔茨海默病。

Int J Neurosci. 2003 Mar;113(3):361-81. doi: 10.1080/00207450390162146.

Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease.双特异性蛋白磷酸酶：癌症和阿尔茨海默病的治疗靶点。

Annu Rev Pharmacol Toxicol. 2005;45:725-50. doi: 10.1146/annurev.pharmtox.45.120403.100040.

Cognitive enhancement therapy for Alzheimer's disease. The way forward.阿尔茨海默病的认知增强疗法。前进的道路。

Drugs. 1997 May;53(5):752-68. doi: 10.2165/00003495-199753050-00003.

Catecholamine neurons with Alzheimer's neurofibrillary changes and alteration of tyrosine hydroxylase. Immunohistochemical investigation of tyrosine hydroxylase.伴有阿尔茨海默病神经原纤维变化及酪氨酸羟化酶改变的儿茶酚胺能神经元。酪氨酸羟化酶的免疫组织化学研究。

Acta Neuropathol. 1985;66(1):37-41. doi: 10.1007/BF00698293.

引用本文的文献

Exome-wide analysis reveals role of and additional novel loci in cognition.外显子组全基因组分析揭示了和其他新的认知相关基因座的作用。

HGG Adv. 2023 May 20;4(3):100208. doi: 10.1016/j.xhgg.2023.100208. eCollection 2023 Jul 13.

Sleep and Late-Onset Alzheimer's Disease: Shared Genetic Risk Factors, Drug Targets, Molecular Mechanisms, and Causal Effects.睡眠与晚发性阿尔茨海默病：共同的遗传风险因素、药物靶点、分子机制及因果效应

Front Genet. 2022 May 17;13:794202. doi: 10.3389/fgene.2022.794202. eCollection 2022.

Activation of tyrosine phosphatase PTP1B in pyramidal neurons impairs endocannabinoid signaling by tyrosine receptor kinase trkB and causes schizophrenia-like behaviors in mice.锥体神经元中酪氨酸磷酸酶PTP1B的激活通过酪氨酸受体激酶trkB损害内源性大麻素信号传导，并在小鼠中引发类似精神分裂症的行为。

Neuropsychopharmacology. 2020 Oct;45(11):1884-1895. doi: 10.1038/s41386-020-0755-3. Epub 2020 Jul 1.

本文引用的文献

Hyperactivated PTP1B phosphatase in parvalbumin neurons alters anterior cingulate inhibitory circuits and induces autism-like behaviors.过度激活的小脑浦肯野细胞神经元中的 PTP1B 磷酸酶改变了前扣带皮层的抑制性回路，并诱导了类似自闭症的行为。

Nat Commun. 2020 Feb 24;11(1):1017. doi: 10.1038/s41467-020-14813-z.

Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.神经元蛋白酪氨酸磷酸酶 1B 加速了小鼠的淀粉样β相关阿尔茨海默病。

J Neurosci. 2020 Feb 12;40(7):1581-1593. doi: 10.1523/JNEUROSCI.2120-19.2019. Epub 2020 Jan 8.

Regulation of Hippocampal Synaptic Function by the Metabolic Hormone, Leptin: Implications for Health and Neurodegenerative Disease.代谢激素瘦素对海马突触功能的调节：对健康和神经退行性疾病的影响

Front Cell Neurosci. 2018 Oct 16;12:340. doi: 10.3389/fncel.2018.00340. eCollection 2018.

Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling.慢性应激通过损害内源性大麻素信号传导的杏仁核细胞内级联反应诱导焦虑。

Neuron. 2015 Mar 18;85(6):1319-31. doi: 10.1016/j.neuron.2015.02.015. Epub 2015 Mar 5.

Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.克拉拉明的功能特性：一种新型蛋白酪氨酸磷酸酶1B抑制剂及胰岛素模拟化合物。

Biochem Biophys Res Commun. 2015 Feb 27;458(1):21-7. doi: 10.1016/j.bbrc.2015.01.040. Epub 2015 Jan 24.

Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.大麻素用于治疗阿尔茨海默病：迈向临床应用

Front Pharmacol. 2014 Mar 5;5:37. doi: 10.3389/fphar.2014.00037. eCollection 2014.

GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex.GABA 能神经胶质细胞是大脑皮层胰岛素的局部来源。

J Neurosci. 2014 Jan 22;34(4):1133-7. doi: 10.1523/JNEUROSCI.4082-13.2014.

The LIM domain only 4 protein is a metabolic responsive inhibitor of protein tyrosine phosphatase 1B that controls hypothalamic leptin signaling.LIM 结构域只有 4 蛋白是一种代谢反应性的蛋白酪氨酸磷酸酶 1B 抑制剂，它控制着下丘脑瘦素信号。

J Neurosci. 2013 Jul 31;33(31):12647-55. doi: 10.1523/JNEUROSCI.0746-13.2013.

LIM domain only 4 (LMO4) regulates calcium-induced calcium release and synaptic plasticity in the hippocampus.LIM 结构域只有 4（LMO4）调节海马体中的钙诱导钙释放和突触可塑性。

J Neurosci. 2012 Mar 21;32(12):4271-83. doi: 10.1523/JNEUROSCI.6271-11.2012.

Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model.基因敲低纹状体富集的酪氨酸磷酸酶（STEP）可逆转阿尔茨海默病小鼠模型的认知和细胞缺陷。

Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19014-9. doi: 10.1073/pnas.1013543107. Epub 2010 Oct 18.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验